Event
6 mins
ASGCT 2026 Annual Meeting – Boston, 11–15 May 2026
11-15 May 2026
Boston, MA
Touchlight will join the global gene and cell therapy community at the ASGCT 2026 Annual Meeting, held May 11–15, 2026 at the Thomas M. Menino Convention & Exhibition Center in Boston, MA.
Visit us at booth # 1334
As a leader in cell‑free DNA manufacturing, Touchlight is shaping the next era of advanced therapy development. At ASGCT, our team will discuss how mbDNA™ and Custom Circles, our next‑generation, circular single‑stranded DNA formats, enable developers to move faster, overcome plasmid constraints, and streamline the path from discovery to clinic.
Throughout the meeting, our commercial and scientific experts will be onsite for discussions so if you’re attending ASGCT, we welcome you to connect with us to explore how Touchlight’s technology can accelerate your pipeline.
🗣️ Oral presentation
Date: Wednesday, 13 May | 9:30–9:45 am
Title: Novel Lipid-Based Formulations for Delivery of Cell-Free Single-Stranded DNA (mbDNA™) Enable Improved HDR Knock‑In in Primary Human T Cells
📈 Posters on display:
- #1859 Reimagining DNA Payloads: Enzymatic Circular DNA for the Next Generation of Cell and Gene Therapies
- #1860 A Comparative Cost of Goods Analysis of dbDNA™ and Plasmid DNA for AAV Gene Therapy Manufacturing
- #749 Cell‑free z‑dbDNA™ Transcription Templates Enable High‑Yield, High‑Quality RNA with Reduced dsRNA Impurity
Visit our posters onsite, or explore and download them directly from our website. We look forward to connecting at ASGCT!
Touchlight Attendees
Karen Fallen: Chief Executive Officer
Verna McErlane, PhD: Chief Commercial Officer
Daniel McCallister: Senior Sales Manager
Jensen Atkins: Senior Sales Manager
Jim Raney: Sales Manager
Request a Meeting
We look forward to meeting you at the event to discuss ways we can help advance your genetic medicine breakthroughs.
